AWM Investment Company Inc. 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 3:47 pm Purchase | 2023-12-31 | 13G | OncoCyte Corporation OCX | AWM Investment Company Inc. | 754,286 9.100% | 391,575![]() (+107.96%) | Filing |
2023-02-14 11:23 am Purchase | 2022-12-31 | 13G | OncoCyte Corporation OCX | AWM Investment Company Inc. | 362,711 6.100% | 362,711![]() (New Position) | Filing |